Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2017 | 07-2016 | 07-2015 | 07-2014 | 12-2013 | |
| Sales | 18,446 | 9,898 | 1,550 | 0 | 0 |
| Gross Profit | 18,446 | 9,898 | 1,550 | N/A | 0 |
| Operating Expenses | 11,353 | 17,636 | 8,450 | 11,303 | 10,839 |
| Operating Income | 7,093 | -7,739 | -6,900 | -11,303 | -10,839 |
| Interest Expense | 0 | 0 | 28 | 160 | 0 |
| Other Income | 38 | -76 | -110 | -19 | 0 |
| Pre-tax Income | 7,131 | -7,814 | -7,038 | -11,483 | -10,839 |
| Income Tax | 551 | N/A | N/A | N/A | 0 |
| Net Income Continuous | 6,581 | -7,814 | -7,038 | -11,483 | -10,839 |
| Net Income | $6,581 | $-7,814 | $-7,038 | $-11,483 | $-11,483 |
| EPS Basic Total Ops | 3.27 | -4.09 | -3.88 | -6.57 | N/A |
| EPS Basic Continuous Ops | 3.27 | -4.09 | -3.88 | -6.57 | N/A |
| EPS Diluted Total Ops | 2.94 | -4.09 | -3.88 | -6.57 | N/A |
| EPS Diluted Continuous Ops | 2.94 | -4.09 | -3.88 | -6.57 | N/A |
| EBITDA(a) | $7,098 | $-7,736 | $-6,898 | $-11,170 | $-10,709 |